AAAAAA

   
Results: 1-7 |
Results: 7

Authors: VILLA E RABANO A CAZES M CLOAREC A RUILOPE LM GARCIAROBLES R
Citation: E. Villa et al., EFFECTS OF UP269-6, A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST, AND CAPTOPRIL ON THE PROGRESSION OF RAT DIABETIC NEPHROPATHY, American journal of hypertension, 10(3), 1997, pp. 275-281

Authors: VIRONEODDOS A DESANGLE V PROVOST D CAZES M CAUSSADE F CLOAREC A
Citation: A. Vironeoddos et al., IN-VITRO AND IN-VIVO EFFECTS OF UP-269-6, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION, British Journal of Pharmacology, 120(3), 1997, pp. 488-494

Authors: CAUSSADE F VIRONEODDOS A DELCHAMBRE C CAZES M VERSIGNY A CLOAREC A
Citation: F. Caussade et al., IN-VITRO PHARMACOLOGICAL CHARACTERIZATION OF UP-269-6, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, Fundamental and clinical pharmacology, 9(2), 1995, pp. 119-128

Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M VIRONEODDOS A CAUSSADE F CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRIMIDINE-DERIVATIVES, European journal of medicinal chemistry, 30(5), 1995, pp. 365-375

Authors: CAZES M PROVOST D VERSIGNY A CLOAREC A
Citation: M. Cazes et al., IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF UP-269-6, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, European journal of pharmacology, 284(1-2), 1995, pp. 157-170

Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M CAUSSADE F VIRONEODDOS A CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND SAR STUDIES OF NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES AS POTENT, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 37(15), 1994, pp. 2371-2386

Authors: NICOLAI E CURE G GOYARD J KIRCHNER M TEULON JM VERSIGNY A CAZES M VIRONEODDOS A CAUSSADE F CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRAZOLE DERIVATIVES, Chemical and Pharmaceutical Bulletin, 42(8), 1994, pp. 1617-1630
Risultati: 1-7 |